Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: Regulators of growth fraction and programmed cell death
J. N. Winter
*
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: Regulators of growth fraction and programmed cell death'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Non-Hodgkin Lymphoma
75%
Biological Product
50%
Prospective Study
50%
Programmed Cell Death
50%
Predictor
50%
Patient
50%
Therapeutic Procedure
50%
Indicator
50%
Combination Therapy
25%
Clinical Feature
25%
Lymphoma
25%
Biological Therapy
25%
Growth
25%
INIS
lymphomas
75%
patients
50%
apoptosis
50%
indicators
50%
chemotherapy
50%
clinical trials
25%
growth
25%
therapy
25%
risks
25%
biology
25%
failures
25%
malignancies
25%
doses
25%
monoclonal antibodies
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Nonhodgkin Lymphoma
75%
Biological Product
50%
Clinical Trial
50%
Indicator
50%
Rituximab
50%
Lymphoma
25%
Clinical Feature
25%